These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16308)

  • 1. A multiclinic double-blind trial of the anxiolytic properties of lorazepam in psychiatric outpatient practice [proceedings].
    Lipman R; Vanov SK; Richards DJ
    Psychopharmacol Bull; 1977 Apr; 13(2):17-9. PubMed ID: 16308
    [No Abstract]   [Full Text] [Related]  

  • 2. Lorazepam in the management of anxiety associated with chronic gastrointestinal disease: a double-blind study.
    Kasich AM
    Curr Ther Res Clin Exp; 1976 Mar; 19(3):292-306. PubMed ID: 5247
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical assessment of lorazepam in anxiety: a double-blind study.
    Olgiati SG
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):13-22. PubMed ID: 237741
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of lorazepam on hypertension-associated anxiety: a double-blind study.
    Hart WL; Parmley LF
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):41-5. PubMed ID: 30767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter trials and complementary studies of cloxazolam, a new anxiolytic drug.
    Fischer-Cornelssen KA
    Arzneimittelforschung; 1981; 31(10):1757-65. PubMed ID: 6119092
    [No Abstract]   [Full Text] [Related]  

  • 6. A clinical assessment of lorazepam in the treatment of anxiety associated with gastrointestinal symptomatology.
    Berkowitz JM
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):46-52. PubMed ID: 30768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lorazepam in anxiety associated with chronic enteritis and ulcerative colitis.
    Stokes DK
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):53-7. PubMed ID: 30769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings: Lorazepam in the treatment of neurosis--an uncontrolled clinical study.
    Ananth V; Beszterczy A; Geagea C
    Psychopharmacol Bull; 1976 Jan; 12(1):19-21. PubMed ID: 1825
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of the safety and therapeutic effects of lorazepam on long-term use.
    Siassi I; Thomas M; Vanov SK
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):163-71. PubMed ID: 240649
    [No Abstract]   [Full Text] [Related]  

  • 10. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind placebo cross-over study of long-acting (chlordesmethyldiazepam) versus short-acting (lorazepam) benzodiazepines in generalized anxiety disorders.
    Bertin I; Colombo G; Furlanut M; Benetello P
    Int J Clin Pharmacol Res; 1989; 9(3):203-8. PubMed ID: 2568350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trial.
    Cutler NR; Sramek JJ; Wardle TS; Hesselink JM; Roeschen JK
    Psychopharmacol Bull; 1993; 29(2):303-8. PubMed ID: 7904761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind cross-over clinical comparison of two 2'-chloro benzodiazepines: 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one (chlordesmethyldiazepam) versus 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one (lorazepam) in neurotic anxiety.
    Andreoli V; Maffei F; Montanaro N; Morandini G
    Arzneimittelforschung; 1977 Feb; 27(2):436-9. PubMed ID: 16622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lorazepam and diazepam in the treatment of neurotic anxiety: a double-blind trial.
    Valarino F; Perez-Lopez R
    Dis Nerv Syst; 1976 Feb; 37(2):58-61. PubMed ID: 1213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical assessment of the safety and efficacy of lorazepam, a new benzodiazepine derivative, in the treatment of anxiety.
    Pinosky DG
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):24-9. PubMed ID: 30763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice.
    Nguyen N; Fakra E; Pradel V; Jouve E; Alquier C; Le Guern ME; Micallef J; Blin O
    Hum Psychopharmacol; 2006 Apr; 21(3):139-49. PubMed ID: 16625522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lorazepam, a new benzodiazepine derivative, in the treatment of anxiety: a double-blind clinical evaluation.
    McCurdy L
    Am J Psychiatry; 1979 Feb; 136(2):187-90. PubMed ID: 32776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lorazepam (Ativan).
    Med Lett Drugs Ther; 1978 Mar; 20(6):31-2. PubMed ID: 24801
    [No Abstract]   [Full Text] [Related]  

  • 19. Antianxiety effects of lorazepam in patients with cardiovascular symptomatology.
    Finkel S
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):35-40. PubMed ID: 30766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A method for evaluating anxiolytic sedatives.
    Wang RI; Wiesen RL; Stockdale S; Hieb E
    J Clin Pharmacol; 1977; 17(5-6):269-75. PubMed ID: 16039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.